Interim Management Statement

British & American Investment Trust PLC Interim Management Statement - 3 months to 30 September 2014 To the members of British & American Investment Trust PLC This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose. This interim management statement relates to the period from 1 July 2014 to 30 September 2014, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified. Investment objective To invest predominantly in investment trusts and other leading UK quoted companies to achieve a balance of income and growth. Benchmark FTSE All-Share Index and FTSE 100 Index. Material developments On 28 August 2014 the company reported its Half Year results to 30 June 2014. An interim ordinary dividend of 2.7p is to be paid on 6 November 2014 to shareholders on the register at 9 October 2014. A dividend of 1.75p per share is to be paid to preference shareholders on 6 November 2014. Twenty largest equity holdings at 30 September 2014 (group basis) % Geron Corporation 16.52 Dunedin Income Growth 10.12 Rit Capital Partners 8.00 British Assets Trust 7.73 Prudential 7.64 St. James's Place Global Equity 7.26 Biotime Inc NPV 4.80 Biotime Series A Convertible Preferred Stock 4.74 Scottish & American Investment Company 3.68 Invesco Income Growth Trust 3.20 Alliance Trust 3.04 F&C Asset Management - 6.75% FRN Sub. Bonds 2026 2.35 Earthport 2.21 Royal & Sun Alliance Insurance Group - 7.375% Cum. irred. preference shares £1 2.02 Shires Income 1.87 Merchants Trust 1.86 Rothschilds Continuation Finance - 9% Perp. Sub. Gtd. Loan Notes 1.80 Asterias Biotherapeutics Series A Common Stock 1.64 Barclays Bank - 9% PIB Capital Bonds 0.98 Jupiter Income Trust 0.86 Total 92.32 Sector allocation as at 30 September 2014 (group basis) % Investment Trusts (equities) 41.32 Biomedical 16.52 Biotechnology 9.72 Unit Trusts 8.12 Life Assurance 7.64 Software and computer services 2.55 Pharmaceuticals 1.78 Other Financial 0.40 Support services 0.34 Telecommunications 0.29 Leisure and hotels 0.15 Overseas 0.09 Financial services 0.07 Fixed Interest Stocks excluding Preference 4.15 Preference 2.59 Derivatives - traded options 2.17 Permanent Interest Bearing 1.21 Property Units - EZT 0.89 Total 100.00 Key facts Performance As at As at As at As at As at 30 30 30 30 30 September September September September September 2014 2014 2013 2011 2009 Year to 1 year 3 years 5 years date Total assets (000) 24,576 Short term borrowings (000) 2,523 Actual gearing 10.38 % NAV (p) 70.2 FTSE All-Share 3,533.93 Share price (p) 84.0 -21.1% -1.8% 21.7% -6.7% Premium/(discount) 19.7% 4.1% -5.3% -6.3% Dividend yield 9.29% 8.89% 10.43% 7.33% Ongoing charges (year ended 31/12/13) 2.26% As at 30 September 2014 1 year 3 years 5 years Value of £100 invested (dividends reinvested) 106.8 162.3 147.5 FTSE ALL-Share 106.1 147.9 159.1 Total Return; Net Income Reinvested, GBP. Source: Walker Crips Stockbrokers Limited and Fundamental Data Limited. Source: Association of Investment Companies and Morningstar. The Board is not aware of any significant events or transactions which have occurred between 30 September 2014 and the date of publication of this interim management statement which would have a material impact on the financial position of the Company. For latest performance information, please refer to the Company's website, www.baitgroup.co.uk. For British & American Investment Trust PLC 29 October 2014
UK 100

Latest directors dealings